CapsoVision, Inc. (CV)

CapsoVision Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	4.4	9.32	14.56
Cash & Cash Equivalents	4.4	9.32	14.56
Cash Growth	-	-35.99%	-
Receivables	1.64	2	1.87
Inventory	3.04	2.63	2.2
Other Current Assets	1.52	0.9	0.58
Total Current Assets	10.59	14.85	19.2
Property, Plant & Equipment	-	0.72	0.77
Goodwill and Intangibles	-	1.2	1.51
Other Long-Term Assets	-	0.04	0.04
Total Long-Term Assets	-	1.96	2.33
Total Assets	-	16.8	21.53
Accounts Payable	-	0.75	0.36
Deferred Revenue	-	0.13	0.1
Current Debt	0.37	0.35	0.28
Other Current Liabilities	2.37	0.57	0.77
Total Current Liabilities	2.73	1.8	1.51
Long-Term Debt	0.79	0.89	1.24
Total Long-Term Liabilities	-	0.89	1.24
Total Liabilities	-	2.69	2.75
Total Debt	1.15	1.24	1.51
Debt Growth	-	-18.23%	-
Retained Earnings	-135.73	-130.35	-110.45
Shareholders' Equity	-134.7	-129.51	-109.84
Net Cash / Debt	3.25	8.08	13.05
Net Cash / Debt Growth	-	-38.05%	-
Working Capital	-	13.05	17.7

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).